Joseph Mikhael, MD

Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO is a professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He is also the chief medical officer of the International Myeloma Foundation (IMF).

Articles by Joseph Mikhael, MD

Discussing Daratumumab’s Ongoing Impact on Multiple Myeloma Treatment

ByJoseph Mikhael, MD

November 2nd 2022

Joseph Mikhael, MD, discusses the ongoing impact of daratumumab in the treatment landscape of patients with multiple myeloma.

Joseph Mikhael, MD

Articles by Joseph Mikhael, MD

Discussing Daratumumab’s Ongoing Impact on Multiple Myeloma Treatment

Latest Updated Articles